A Bad Sign For Healthcare Venture Capital

Dan Primack of Fortune magazine has a post today on his blog, Term Sheet, about how one prominent venture capital firm is shutting down its investments in healthcare. This is not good sign.

The firm,  Scale Venture Partners, cites the challenges of getting new drug submissions through the FDA as the basis for its actions.

A vibrant interest in healthcare by venture capital and private equity is critical to advancements in new therapies and devices.  Government policies that chill investments in these areas are a problem and should be changed.


About Bill Cadigan

WILLIAM J. CADIGAN is principal in the Law Office of William J. Cadigan, P.C. located in Chicago, Illinois. Before starting his own firm, Bill Cadigan was a member of the Health Industry Group of the law firm of Akin, Gump, Strauss, Hauer & Feld L.L.P.
This entry was posted in Venture Capital & Private Equity. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s